XGENE PHARMACEUTICAL Trademark

Trademark Overview


On Tuesday, April 13, 2021, a trademark application was filed for XGENE PHARMACEUTICAL with the United States Patent and Trademark Office. The USPTO has given the XGENE PHARMACEUTICAL trademark a serial number of 90642191. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Tuesday, November 7, 2023. This trademark is owned by XGENE PHARMACEUTICAL INC.. The XGENE PHARMACEUTICAL trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Vaccines; Medicines for human purposes, namely, medicines for treatment of cancer; Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical products for the treatment of cancer; Biological preparations for the treatment of cancer; Pain relief medication; Biological preparations for medical purposes, namely, biological preparations for the treatment of cancer; Antibiotics; Chemico-pharmaceutical preparations for treatment of cancer; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for treating skin disorders; Dermatological pharmaceutical products; Herbicide for agricultural use; Pesticides for agricultural use; Fungicides for agricultural use; Medicines for veterinary purposes, namely, killing insects

Chemical research; Chemical analysis; Chemistry consultation; Cosmetic research; Biological research; Scientific research; Scientific research and development; Research and development of new products for others; Medical research; Technological research in the field of medical instruments; Product quality testing; Scientific research for medical purposes in the area of cancerous diseases
xgene pharmaceutical

General Information


Serial Number90642191
Word MarkXGENE PHARMACEUTICAL
Filing DateTuesday, April 13, 2021
Status730 - FIRST EXTENSION - GRANTED
Status DateTuesday, November 7, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 28, 2023

Trademark Statements


Description of MarkThe mark consists of a design consisting of a series of geometric shapes, together forming a hexagon. Beginning at the top of the design and moving counter clockwise, the shapes are a blue triangle, a blue diamond, two green diamonds and a sixth negative space bordered by the letter X in term XGENE, which is at the top right of the design element with the letter X in the colors blue and green, and the letters GENE in the color blue. The green term PHARMACEUTICAL is to the right of the design image and beneath the term XGENE.
Goods and ServicesVaccines; Medicines for human purposes, namely, medicines for treatment of cancer; Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical products for the treatment of cancer; Biological preparations for the treatment of cancer; Pain relief medication; Biological preparations for medical purposes, namely, biological preparations for the treatment of cancer; Antibiotics; Chemico-pharmaceutical preparations for treatment of cancer; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for treating skin disorders; Dermatological pharmaceutical products; Herbicide for agricultural use; Pesticides for agricultural use; Fungicides for agricultural use; Medicines for veterinary purposes, namely, killing insects
Indication of Colors claimedThe color(s) blue and green is/are claimed as a feature of the mark.
Disclaimer with Predetermined Text"PHARMACEUTICAL"
Goods and ServicesChemical research; Chemical analysis; Chemistry consultation; Cosmetic research; Biological research; Scientific research; Scientific research and development; Research and development of new products for others; Medical research; Technological research in the field of medical instruments; Product quality testing; Scientific research for medical purposes in the area of cancerous diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, July 20, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, July 20, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameXGENE PHARMACEUTICAL INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGRAND CAYMAN KY1-1205
KY

Party NameXGENE PHARMACEUTICAL INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGRAND CAYMAN KY1-1205
KY

Trademark Events


Event DateEvent Description
Thursday, November 9, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 7, 2023SOU EXTENSION 1 GRANTED
Tuesday, November 7, 2023SOU EXTENSION 1 FILED
Tuesday, November 7, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, May 23, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 28, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 28, 2023PUBLISHED FOR OPPOSITION
Wednesday, March 8, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, February 22, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 17, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, January 17, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 17, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, July 18, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, July 18, 2022NON-FINAL ACTION E-MAILED
Monday, July 18, 2022NON-FINAL ACTION WRITTEN
Thursday, June 2, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 2, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 2, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, December 3, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, December 3, 2021NON-FINAL ACTION E-MAILED
Friday, December 3, 2021NON-FINAL ACTION WRITTEN
Friday, December 3, 2021ASSIGNED TO EXAMINER
Wednesday, July 21, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, July 20, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, April 16, 2021NEW APPLICATION ENTERED